Verrica Pharmaceuticals Inc. Balance Sheet
VRCA|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Verrica Pharmaceuticals Inc. had $47M in total assets with negative shareholders' equity of $10M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $30.1M | $46.3M | $69.5M | $34.3M | $15.8M |
| Accounts Receivable | $5.3M | $48.0K | $4.2M | - | - |
| Inventory | $2.2M | $2.5M | $1.0M | - | - |
| Current Assets | $42.5M | $51.2M | $77.5M | $39.1M | $74.3M |
| PP&E (Net) | $209.0K | $589.0K | $1.1M | $3.9M | $3.9M |
| Total Assets | $47.1M | $54.1M | $81.6M | $44.7M | $80.1M |
| Current Liabilities | $16.4M | $29.0M | $17.0M | $3.5M | $46.1M |
| Total Debt | - | $31.0M | $42.9M | - | - |
| Shareholders' Equity | -$9.9M | $19.8M | $40.0M | $32.6M | $33.0M |